PSQ Holdings, Inc. (PublicSq.) — Q3 2023 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2023. The company operates a values-focused consumer and business marketplace and, since July 2023, the EveryLife diapers-and-wipes brand. Its July 19, 2023 business combination was accounted for as a reverse recapitalization; prior-period comparisons reflect PSQ’s predecessor operations.
Financial performance and position
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Revenue | $2.03 million | $0.12 million | $2.94 million | $0.20 million |
| Operating loss | $12.98 million | $2.13 million | $25.71 million | $4.77 million |
| Net loss | $20.24 million | $2.12 million | $47.65 million | $4.76 million |
| Adjusted EBITDA (non-GAAP) | $(7.72) million | $(1.92) million | $(15.47) million | $(4.29) million |
| Net cash used in operations | Not separately presented | Not separately presented | $12.27 million | $4.22 million |
- Q3 revenue comprised $875,546 of marketplace advertising and $1.16 million of EveryLife sales after $232,597 in returns and discounts. Nine-month revenue was $1.78 million from advertising and $1.16 million from EveryLife.
- Calculated gross profit was approximately $0.56 million for Q3 (28% of revenue) and $0.85 million for the nine months (29%), based on revenue less service costs and cost of goods sold.
- At September 30, cash and cash equivalents were $25.26 million; current assets were $30.34 million and current liabilities $3.19 million, with reported net working capital of $27.15 million. Total assets were $33.25 million and stockholders’ equity $11.51 million.
- No convertible-note balance remained at quarter-end: $22.5 million of notes plus accrued amounts converted to equity at the business-combination closing. The balance sheet showed $16.60 million of warrant liabilities and $1.95 million of earn-out liabilities; these are fair-value liabilities, not conventional borrowings. Operating lease liabilities totaled $168,608.
Changes versus prior comparable periods
- Revenue increased by $1.91 million in Q3 and $2.74 million year to date, reflecting advertising growth and the launch of EveryLife. Active consumer members exceeded 1.59 million and business members reached 70,955 at September 30; management reported year-over-year growth of 646% and 224%, respectively.
- Losses widened as operating expenses rose substantially, including marketing, staffing, research and development, and business-combination costs. Q3 business-combination costs were $3.31 million; nine-month costs were $7.05 million.
- Nine-month net loss included noncash fair-value losses of $14.57 million on convertible notes and $7.78 million on warrants. The notes subsequently converted; warrant remeasurement remains a source of earnings volatility.
- Operating cash use increased by $8.06 million year over year. Financing provided $37.07 million in the first nine months, principally from convertible notes and the business combination.
Outlook, risks and unusual items
- Management believes cash and business-combination proceeds will fund operations and capital needs for at least one year from the financial statements’ issuance date. It expects continued investment in platform development, marketing, engineering, e-commerce and direct-to-consumer products, and anticipates expenses may rise. No numerical revenue or earnings guidance was provided.
- The company received $34.94 million of gross business-combination proceeds after redemptions; $16.83 million of transaction and advisory costs were paid, leaving $18.10 million of net proceeds. Management says additional financing may be needed if growth spending or revenue performance makes current resources insufficient; further financing may not be available on acceptable terms.
- Warrants for 11.45 million shares have an $11.50 exercise price. The filing notes the November 13, 2023 share price was $6.78 and does not assume cash proceeds from future warrant exercises.
- Subsequent to quarter-end, the company entered a one-year $1.0 million advertising commitment and a Florida headquarters lease with monthly base rent of $16,457 through January 2025. At September 30, remaining commitments under two earlier advertising agreements were not clearly stated.
- Management disclosed a material weakness in internal control over financial reporting; disclosure controls were deemed ineffective as of September 30. Remediation is underway and is expected to require time and resources.
- Related-party arrangements include a board-member-controlled consulting firm’s $80,000 monthly fee plus expenses and a separate board-member advisory agreement for $10,000 monthly plus 40,000 RSUs. The former COO’s separation agreement provides for continued base salary for 12 months, subject to its terms.
- The CEO held approximately 52.8% of voting power through Class C shares. The company also reported 3.12 million RSUs granted, $22.4 million of unrecognized RSU compensation cost, and potential earn-out awards of up to 3 million shares.
- The company reported no pending litigation expected to have a material adverse effect and no off-balance-sheet arrangements.
Important facts for investors to verify
- Whether marketplace monetization and EveryLife sales grow sufficiently to reduce operating losses and cash burn.
- How much of the reported losses reflects recurring operations versus transaction costs and fair-value remeasurements.
- Cash runway assumptions, planned spending, and whether additional financing will be required.
- Potential dilution from RSUs, earn-out shares and warrants, and the effects of CEO voting control.
- Progress and timing of remediation of the material weakness and ineffective disclosure controls.
- Terms, total costs and governance oversight of related-party consulting arrangements and advertising commitments.